Ceftriaxone-induced hemolytic anemia managed successfully in a 54-year-old woman: a case report and literature review
Ceftriaxone is widely used in clinical practice for its efficacy against infections. However, its increasing association with life-threatening immune hemolytic reactions urge clinicians to enhance recognition and maintain sharp vigilance. This report details a rare and severe case of ceftriaxone-ind...
Saved in:
| Main Authors: | Liqian Zhang, Wenfeng Huang, Jiakai Xu, Yunxing Li, Jihong Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1505366/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin
by: Aysel Vehapoğlu, et al.
Published: (2016-04-01) -
Unraveling the complexity: Case reports of drug-induced hemolytic anemia due to ceftriaxone
by: Anshika Yadav, et al.
Published: (2024-12-01) -
Ceftriaxone-induced immune hemolytic anemia: a case report
by: Li Wang, et al.
Published: (2025-03-01) -
Autoimmune Hemolytic Anemia as Presentation of Celiac Disease
by: Ahmed Abdul Hadi Mohsen, et al.
Published: (2022-12-01) -
Autoimmune Hemolytic Anemia in the Course of Pediatric Acute Leukemia and After Hematopoietic Stem Cell Transplantation
by: Sırma Karamercan, et al.
Published: (2025-07-01)